shortagewatch

Home / Tamsulosin and Solifenacin / Belgium

BE ATC G04CA53 · updated 2 Nov 2026

Tamsulosin and Solifenacin shortage in Belgium

Is there a Tamsulosin and Solifenacin shortage in Belgium?

Yes. As of 2 Nov 2026, 8 Tamsulosin and Solifenacin products are reported short in Belgium, the first since 23 Feb 2026. The company estimate for the return is 16 Nov 2026 (latest 16 Dec 2026). Main reason: other.

Also short in Italy, Spain, Austria, Czechia. All countries.

Affected products in Belgium

CountryProductCompanySinceExpected backReason
BESolifenacine/Tamsulosine Viatris 6 mg - 0.4 mg tabl. modif.-rel. 90 (90 x 1) UDViatris GX23 Feb 202616 Dec 2026Other
Other reason
BESolifenacine/Tamsulosine AB 6 mg - 0.4 mg tabl. modif.-rel. 90Aurobindo17 Apr 202615 Dec 2026Other
Other reason
BESolifenacine/Tamsulosine Viatris 6 mg - 0.4 mg tabl. modif.-rel. 200Viatris GX7 Jul 202616 Dec 2026Other
Other reason
BESolifenacine/Tamsulosine Viatris 6 mg - 0.4 mg tabl. modif.-rel. 30 (30 x 1) UDViatris GX5 Aug 202618 Nov 2026Other
Other reason
BESolifenacine/Tamsulosine EG 6 mg - 0.4 mg tabl. modif.-rel. 30 (30 x 1) UDEG10 Aug 202616 Nov 2026Manufacturing problem
Delay in production
BESolifenacine/Tamsulosine EG 6 mg - 0.4 mg tabl. modif.-rel. 90 (90 x 1) UDEG10 Aug 202616 Nov 2026Manufacturing problem
Delay in production
BESolifenacine/Tamsulosine AB 6 mg - 0.4 mg tabl. modif.-rel. 30Aurobindo26 Aug 202615 Dec 2026Other
Other reason
BESolifenacine/Tamsulosine Teva 6 mg - 0.4 mg tabl. modif.-rel. 90 (90 x 1) UDTeva14 Sep 202623 Nov 2026Increased demand

Source

FAMHP (Federal Agency for Medicines and Health Products), PharmaStatus / SAMv2. Official list. All authorised packs with a declared temporary unavailability.